The TB structural genomics consortium: a resource for Mycobacterium tuberculosis biology.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Tuberculosis

• Publication date

  2003-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S1472-9792(03)00051-9PMID 12906835
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Expectations from structural genomics

  2008cited by this paper
• Structural genomics of Mycobacterium tuberculosis: a preliminary report of progress at UCLA.

  2003cited by this paper
• Heterologous expression, purification, and enzymatic activity of Mycobacterium tuberculosis NAD(+) synthetase.

  2002cited by this paper
• Multicopy crystallographic refinement of a relaxed glutamine synthetase from Mycobacterium tuberculosis highlights flexible loops in the enzymatic mechanism and its regulation.

  2002cited by this paper
• Crystallization and preliminary X-ray crystallographic analysis of the Rv2002 gene product from Mycobacterium tuberculosis, a beta-ketoacyl carrier protein reductase homologue.

  2002cited by this paper
• Structure of Mycobacterium tuberculosis chaperonin-10 at 3.5 A resolution.

  2002cited by this paper
• A covalent modification of NADP+ revealed by the atomic resolution structure of FprA, a Mycobacterium tuberculosis oxidoreductase.

  2002cited by this paper
• Crystal structure of a major secreted protein of Mycobacterium tuberculosis—MPT63 at 1.5‐Å resolution

  2002cited by this paper
• Massive gene decay in the leprosy

  2001cited by this paper
• Regulation of the Mycobacterium tuberculosis hypoxic response gene encoding α-crystallin

  2001cited by this paper
• Crystal structure of cytochrome P450 14α-sterol demethylase (CYP51) from Mycobacterium tuberculosis in complex with azole inhibitors

  2001cited by this paper
• Mycobacteria, Molecular Biology and Virulence

  2001cited by this paper
• Massive gene decay in the leprosy bacillus

  2001cited by this paper
• Biochemical characterization of the thioredoxin domain of Escherichia coli DsbE protein reveals a weak reductant.

  2001cited by this paper
• Metal ions modulate the plastic nature of Mycobacterium tuberculosis chaperonin-10.

  2001cited by this paper
• Transcriptional Regulation of furAand katG upon Oxidative Stress inMycobacterium smegmatis

  2001cited by this paper
• High Extracellular Levels of Mycobacterium tuberculosis Glutamine Synthetase and Superoxide Dismutase in Actively Growing Cultures Are Due to High Expression and Extracellular Stability Rather than to a Protein-Specific Export Mechanism

  2001cited by this paper
• Regulation of the Mycobacterium tuberculosis hypoxic response gene encoding alpha -crystallin.

  2001cited by this paper
• The crystal structure of phosphinothricin in the active site of glutamine synthetase illuminates the mechanism of enzymatic inhibition.

  2001cited by this paper
• Cloning, purification and characterisation of Staphylococcus warneri lipase 2.

  2001cited by this paper
• An interfacial mechanism and a class of inhibitors inferred from two crystal structures of the Mycobacterium tuberculosis 30 kDa major secretory protein (Antigen 85B), a mycolyl transferase.

  2001cited by this paper
• Mycobacterial FurA is a negative regulator of catalase–peroxidase gene katG

  2001cited by this paper
• Regulation of catalase–peroxidase (KatG) expression, isoniazid sensitivity and virulence by furA of Mycobacterium tuberculosis

  2001cited by this paper
• Overview of the tunable beamlines for protein crystallography at the EMBL Hamburg Outstation; an analysis of current and future usage and developments.

  2001cited by this paper
• Three-dimensional Structure of Mycobacterium tuberculosis Chaperonin-10 Reveals a Partially Stable Conformation for its Mobile Loop

  2001cited by this paper
• Transcriptional Regulation of furA and katG upon Oxidative Stress in Mycobacterium smegmatis

  2001cited by this paper
• 2-Methylisocitrate lyases from the bacterium Escherichia coli and the filamentous fungus Aspergillus nidulans: characterization and comparison of both enzymes.

  2001cited by this paper
• Persistence of Mycobacterium tuberculosis in macrophages and mice requires the glyoxylate shunt enzyme isocitrate lyase

  2000cited by this paper
• Inhibition of Ca2+ Signaling by Mycobacterium tuberculosisIs Associated with Reduced Phagosome–Lysosome Fusion and Increased Survival within Human Macrophages

  2000cited by this paper
• Secreted lipases of Candida albicans: cloning, characterisation and expression analysis of a new gene family with at least ten members

  2000cited by this paper
• Identification of Genes Encoding Exported Mycobacterium tuberculosis Proteins Using a Tn552′phoA In Vitro Transposition System

  2000cited by this paper
• Crystal structure of the secreted form of antigen 85C reveals potential targets for mycobacterial drugs and vaccines

  2000cited by this paper
• The Saccharomyces cerevisiae ICL2 Gene Encodes a Mitochondrial 2-Methylisocitrate Lyase Involved in Propionyl-Coenzyme A Metabolism

  2000cited by this paper
• Structure of isocitrate lyase, a persistence factor of Mycobacterium tuberculosis

  2000cited by this paper
• Characterization of the Mycobacterium tuberculosis iniBAC Promoter, a Promoter That Responds to Cell Wall Biosynthesis Inhibition

  2000cited by this paper
• The crystal structure and active site location of isocitrate lyase from the fungus Aspergillus nidulans.

  2000cited by this paper
• The domains of human fibronectin mediating the binding of alpha antigen, the most immunopotent antigen of mycobacteria that induces protective immunity against mycobacterial infection.

  2000cited by this paper
• GroES co‐chaperonin small‐angle X‐ray scattering study shows ring orifice increase in solution

  2000cited by this paper
• Structural evidence for evolution of the beta/alpha barrel scaffold by gene duplication and fusion.

  2000cited by this paper
• The structure and function of the β2‐adaptin appendage domain

  2000cited by this paper
• An overview of structural genomics

  2000cited by this paper
• Identification of Secreted Proteins ofMycobacterium tuberculosis by a Bioinformatic Approach

  2000cited by this paper
• The genome sequence of Mycobacterium tuberculosis reveals cytochromes P450 as novel anti-TB drug targets

  2000cited by this paper
• The X-ray Structure of Epoxide Hydrolase from Agrobacterium radiobacter AD1

  1999cited by this paper
• Crystal structure of the iron-dependent regulator (IdeR) from Mycobacterium tuberculosis shows both metal binding sites fully occupied.

  1999cited by this paper
• Conserved structural features and sequence patterns in the GroES fold family.

  1999cited by this paper
• T-Cell Epitope Mapping of the Three Most Abundant Extracellular Proteins of Mycobacterium tuberculosis in Outbred Guinea Pigs

  1999cited by this paper
• Identification of Mycobacterium tuberculosis RNAs synthesized in response to phagocytosis by human macrophages by selective capture of transcribed sequences (SCOTS).

  1999cited by this paper
• An Inhibitor of Exported Mycobacterium tuberculosis Glutamine Synthetase Selectively Blocks the Growth of Pathogenic Mycobacteria in Axenic Culture and in Human Monocytes: Extracellular Proteins as Potential Novel Drug Targets

  1999cited by this paper
• Rapid protein-folding assay using green fluorescent protein

  1999cited by this paper
• Characterization and catalytic properties of the sterol 14alpha-demethylase from Mycobacterium tuberculosis.

  1999cited by this paper
• The 2.8 A crystal structure of visual arrestin: a model for arrestin's regulation.

  1999cited by this paper
• Crystal structure of 7,8-dihydroneopterin triphosphate epimerase.

  1999cited by this paper
• Comparative proteome analysis of Mycobacterium tuberculosis and Mycobacterium bovis BCG strains: towards functional genomics of microbial pathogens

  1999cited by this paper
• SFCHECK: a unified set of procedures for evaluating the quality of macromolecular structure-factor data and their agreement with the atomic model.

  1999cited by this paper
• A dynamic two‐dimensional polyacrylamide gel electrophoresis database: The mycobacterial proteome via Internet

  1999cited by this paper
• The GroES antigens of Mycobacterium avium and Mycobacterium paratuberculosis.

  1999cited by this paper
• Enzymology of NAD+ synthesis.

  1999cited by this paper
• Preliminary crystallographic studies on glutamine synthetase from Mycobacterium tuberculosis.

  1999cited by this paper
• X-ray structure of epoxide hydrolase from Agrobacterium radiobacter AD1 : An enzyme to detoxify harmful epoxides

  1999cited by this paper
• Crystallization, x-ray diffraction and preliminary structure analysis of Mycobacterium tuberculosis chaperonin 10.

  1999cited by this paper
• Electron avenue: pathways of disulfide bond formation and isomerization.

  1999cited by this paper
• Exploring drug-induced alterations in gene expression in Mycobacterium tuberculosis by microarray hybridization.

  1999cited by this paper
• Cloning, expression and significance of MPT53 for identification of secreted proteins of Mycobacterium tuberculosis.

  1999cited by this paper
• GroEL-GroES cycling: ATP and nonnative polypeptide direct alternation of folding-active rings.

  1999cited by this paper
• Expression of hormone-sensitive lipase and its regulation by adrenaline in skeletal muscle.

  1999cited by this paper
• Characterization of Activity and Expression of Isocitrate Lyase in Mycobacterium avium andMycobacterium tuberculosis

  1999cited by this paper
• Learning from the genome sequence of Mycobacterium tuberculosis H37Rv

  1999cited by this paper
• Mycobacteria : molecular biology and virulence

  1999cited by this paper
• A Model for Arrestin’s Regulation: The 2.8 Å Crystal Structure of Visual Arrestin

  1999cited by this paper
• Crystal structure of invasin: a bacterial integrin-binding protein.

  1999cited by this paper
• Crystallography & NMR system: A new software suite for macromolecular structure determination.

  1998cited by this paper
• The Novel Fibronectin-binding Motif and Key Residues of Mycobacteria*

  1998cited by this paper
• T-Cell Recognition of Mycobacterial GroES Peptides in Thai Leprosy Patients and Contacts

  1998cited by this paper
• Erratum: Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence

  1998cited by this paper
• The immunoglobulin superfamily: An insight on its tissular, species, and functional diversity

  1998cited by this paper
• Crystal structure and reaction mechanism of 7,8-dihydroneopterin aldolase from staphylococcus aureus

  1998cited by this paper
• Multidrug-resistant Mycobacterium tuberculosis: molecular perspectives.

  1998cited by this paper
• Identification of differentially expressed mRNA in prokaryotic organisms by customized amplification libraries (DECAL): the effect of isoniazid on gene expression in Mycobacterium tuberculosis.

  1998cited by this paper
• Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence

  1998cited by this paper
• Inhibitors of branched-chain amino acid biosynthesis as potential antituberculosis agents.

  1998cited by this paper
• Class‐directed structure determination: Foundation for a protein structure initiative

  1998cited by this paper
• The MTCY428.08 Gene ofMycobacterium tuberculosis Codes for NAD+ Synthetase

  1998cited by this paper
• SWISS‐MODEL and the Swiss‐Pdb Viewer: An environment for comparative protein modeling

  1997cited by this paper
• Structural adaptations in the specialized bacteriophage T4 co-chaperonin Gp31 expand the size of the Anfinsen cage.

  1997cited by this paper
• The crystal structure of the asymmetric GroEL–GroES–(ADP)7 chaperonin complex

  1997cited by this paper
• Determinants of T cell reactivity to the Mycobacterium leprae GroES homologue.

  1997cited by this paper
• Cysteine 195 Has a Critical Functional Role in Catalysis by Isocitrate Lyase from Escherichia coli

  1997cited by this paper
• Molecular cloning, purification, and serological characterization of MPT63, a novel antigen secreted by Mycobacterium tuberculosis

  1997cited by this paper
• Lysine 194 Is Functional in Isocitrate Lyase from Escherichia coli

  1997cited by this paper
• Propionate catabolism in Salmonella typhimurium LT2: two divergently transcribed units comprise the prp locus at 8.5 centisomes, prpR encodes a member of the sigma-54 family of activators, and the prpBCDE genes constitute an operon

  1997cited by this paper
• The complete genome sequence of the Gram-positive bacterium Bacillus subtilis

  1997cited by this paper
• Cross-validated maximum likelihood enhances crystallographic simulated annealing refinement.

  1997cited by this paper
• Temperature dependence of backbone dynamics in loops of human mitochondrial heat shock protein 10.

  1997cited by this paper
• Role of the major antigen of Mycobacterium tuberculosis in cell wall biogenesis.

  1997cited by this paper
• Mycobacterium tuberculosis Chaperonin 10 Stimulates Bone Resorption: A Potential Contributory Factor in Pott's Disease

  1997cited by this paper
• Serine319 and 321 Are Functional in Isocitrate Lyase from Escherichia coli

  1997cited by this paper
• Crystal structure of the anti-bacterial sulfonamide drug target dihydropteroate synthase

  1997cited by this paper
• P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature.

  1996cited by this paper
• xdlMAPMAN and xdlDATAMAN - programs for reformatting, analysis and manipulation of biomacromolecular electron-density maps and reflection data sets.

  1996cited by this paper

• Genome wide screening to discover novel toxin–antitoxin modules in Mycobacterium indicus pranii; perspective on gene acquisition during mycobacterial evolution

  2024cites this paper
• Structural variability of Mycobacterium tuberculosis SSB and susceptibility to inhibition

  2022cites this paper
• Structure-based in silico approaches for drug discovery against Mycobacterium tuberculosis

  2021cites this paper
• A Comprehensive Review onMycobacterium tuberculosisTargets and Drug Development from a Structural Perspective

  2020cites this paper
• Bioinformatics And Tuberculosis Databases-A Systematic Review

  2020cites this paper
• Structure-Based Drug Design for Tuberculosis: Challenges Still Ahead

  2020cites this paper
• Two Decades of TB Drug Discovery Efforts—What Have We Learned?

  2020cites this paper
• Plasticity, ligand conformation and enzyme action of Mycobacterium smegmatis MutT1.

  2020cites this paper
• The pMy vector series: A versatile cloning platform for the recombinant production of mycobacterial proteins in Mycobacterium smegmatis

  2020cites this paper
• Pediatric Tuberculosis: The Impact of “Omics” on Diagnostics Development

  2020cites this paper
• Biochemical characterization of Mycobacterium tuberculosis LexA and structural studies of its C-terminal segment.

  2019cites this paper
• Bioinformatics and Drug Discovery

  2019cites this paper
• Structural studies on M. tuberculosis argininosuccinate lyase and its liganded complex: Insights into catalytic mechanism

  2019cites this paper
• Mycobacterium tuberculosis LexA C-domain K197A

  2019cites this paper
• Argininosuccinate lyase from Mycobacterium tuberculosis

  2019cites this paper
• Structure and interactions of RecA: plasticity revealed by molecular dynamics simulations

  2018cites this paper
• The crystal structure of the drug target Mycobacterium tuberculosis methionyl-tRNA synthetase in complex with a catalytic intermediate.

  2018cites this paper
• Overview of the Development of DprE1 Inhibitors for Combating the Menace of Tuberculosis.

  2018cites this paper
• Hydrolysis of diadenosine polyphosphates. Exploration of an additional role of Mycobacterium smegmatis MutT1.

  2017cites this paper
• The Proteome of Mycobacterium tuberculosis in Three Dimensions

  2017cites this paper
• New active leads for tuberculosis booster drugs by structure-based drug discovery.

  2017cites this paper
• Biochemical and structural studies of Mycobacterium smegmatis MutT1, a sanitization enzyme with unusual modes of association.

  2017cites this paper
• Biochemical and structural studies of mutants indicate concerted movement of the dimer interface and ligand-binding region of Mycobacterium tuberculosis pantothenate kinase.

  2017cites this paper
• Cell Wall Associated Factors of Mycobacterium tuberculosis as Major Virulence Determinants: Current Perspectives in Drugs Discovery and Design.

  2017cites this paper
• Recent advancements in the development of anti-tuberculosis drugs.

  2017cites this paper
• Functional, structural and epitopic prediction of hypothetical proteins of Mycobacterium tuberculosis H37Rv: An in silico approach for prioritizing the targets.

  2016cites this paper
• Structural studies on Mycobacterium tuberculosis RecA: Molecular plasticity and interspecies variability

  2015cites this paper
• Tuberculosis: An Inorganic Medicinal Chemistry Perspective.

  2015cites this paper
• Production of recombinant proteins in Mycobacterium smegmatis for structural and functional studies

  2015cites this paper
• Structural plasticity in Mycobacterium tuberculosis uracil-DNA glycosylase (MtUng) and its functional implications.

  2015cites this paper
• BIOINFORMATICS AND TB VACCINE DEVELOPMENT: A COMPARATIVE GENOMIC APPROACH

  2014cites this paper
• Optimization of phage heptapeptide library-screening process for developing inhibitors of the isocitrate lyase homologue from Mycobacterium tuberculosis

  2014cites this paper
• Simulating interaction of tuberculosis antigen 85B protein with hydrophobic surface graphene

  2013cites this paper
• Comparison with other tagging methods Detailed applications Using GFP to Monitor Protein Expression ( SuperFolder GFP , Split GFP )

  2013cites this paper
• Molecular flexibility of Mycobacterium tuberculosis ribosome recycling factor and its functional consequences: An exploration involving mutants

  2013cites this paper
• Machine learning and tubercular drug target recognition.

  2013cites this paper
• Structure of arylamine N-acetyltransferase from Mycobacterium tuberculosis determined by cross-seeding with the homologous protein from M. marinum: triumph over adversity.

  2013cites this paper
• New approaches to tuberculosis--novel drugs based on drug targets related to toll-like receptors in macrophages.

  2013cites this paper
• Genetic Essentiality, Biochemical and Structural Properties of Fructose 1,6-bisphosphatases II

  2013cites this paper
• CrystalDirect: a new method for automated crystal harvesting based on laser-induced photoablation of thin films.

  2012cites this paper
• In silico analysis of DosR regulon proteins of Mycobacterium tuberculosis.

  2012cites this paper
• Quantum dots nanoparticle-based lateral flow assay for rapid detection of Mycobacterium species using anti-FprA antibodies

  2012cites this paper
• Web tools for molecular epidemiology of tuberculosis.

  2012cites this paper
• Synthesis and biological evaluation of chalcones and acetyl pyrazoline derivatives comprising furan nucleus as an antitubercular agents

  2012cites this paper
• Synthesis and characterization of pyruvate-isoniazid analogs and their copper complexes as potential ICL inhibitors.

  2012cites this paper
• TubercuList e 10 years after

  2011cites this paper
• Molecular modeling studies of Fatty acyl-CoA synthetase (FadD13) from Mycobacterium tuberculosis—a potential target for the development of antitubercular drugs

  2011cites this paper
• Expression, purification and preliminary crystallographic analysis of O-acetylhomoserine sulfhydrylase from Mycobacterium tuberculosis.

  2011cites this paper
• TubercuList--10 years after.

  2011cites this paper
• Computational databases, pathway and cheminformatics tools for tuberculosis drug discovery.

  2011cites this paper
• Managing knowledge assets under conditions of radical change: The case of the pharmaceutical industry

  2011cites this paper
• Structural biology of Mycobacterium tuberculosis proteins: the Indian efforts.

  2011cites this paper
• Computational tools to study and understand the intricate biology of mycobacteria.

  2011cites this paper
• The TB Structural Genomics Consortium: a decade of progress.

  2011cites this paper
• Exploring drug target flexibility using in situ click chemistry: application to a mycobacterial transcriptional regulator.

  2010cites this paper
• The Mycobacterium tuberculosis Drugome and Its Polypharmacological Implications

  2010cites this paper
• Preliminary X-ray crystallographic analysis of ornithine acetyltransferase (Rv1653) from Mycobacterium tuberculosis.

  2009cites this paper
• A enzima 2-trans-enoil-ACP (COA) redutase de Mycobacterium tuberculosis : inibição por um novo composto e estudos espectroscópicos do seu mecanismo de resistência à hidrazida do ácido isonicotínico

  2009cites this paper
• Benefits of structural genomics for drug discovery research.

  2009cites this paper
• Expression, purification and preliminary crystallographic analysis of N-acetylglucosamine-1-phosphate uridylyltransferase from Mycobacterium tuberculosis.

  2008cites this paper
• A Knowledge Perspective of Strategic Alliances and Management of Biopharmaceutical Innovation: Evolving Research Paradigms

  2008cites this paper
• Recent advances in antituberculous drug development and novel drug targets

  2008cites this paper
• targetTB: A target identification pipeline for Mycobacterium tuberculosis through an interactome, reactome and genome-scale structural analysis

  2008cites this paper
• Development of new antituberculous agents based on new drug targets and structure–activity relationship

  2008cites this paper
• Cloning, expression, purification, crystallization and preliminary X-ray crystallographic analysis of bacterioferritin A from Mycobacterium tuberculosis.

  2008cites this paper
• The crystal structures of ornithine carbamoyltransferase from Mycobacterium tuberculosis and its ternary complex with carbamoyl phosphate and L-norvaline reveal the enzyme's catalytic mechanism.

  2008cites this paper
• TB database: an integrated platform for tuberculosis research

  2008cites this paper
• Structure of the C-terminal domain of the arginine repressor protein from Mycobacterium tuberculosis.

  2008cites this paper
• Structure-based approaches to drug discovery against tuberculosis.

  2007cites this paper
• Mycobacterial shikimate pathway enzymes as targets for drug design.

  2007cites this paper
• Expression, purification and preliminary X-ray analysis of the C-terminal domain of an arginine repressor protein from Mycobacterium tuberculosis.

  2007cites this paper
• Structural genomics as an approach towards understanding the biology of tuberculosis

  2007cites this paper
• Cloning, expression, purification, crystallization and preliminary X-ray crystallographic analysis of initiation factor 1 from Mycobacterium tuberculosis.

  2007cites this paper
• Recent Advances in Methodologies for the Discovery of Antimycobacterial Drugs

  2007cites this paper
• Introduction to Pathogenomics

  2007cites this paper
• Structural genomics of mycobacterium tuberculosis: a search for function and new drug targets

  2007cites this paper
• Scanning the genome of Mycobacterium tuberculosis to identify potential lectins.

  2007cites this paper
• Current strategies for identifying and validating targets for new treatment-shortening drugs for TB.

  2007cites this paper
• Heterologous expression of proteins from Plasmodium falciparum: results from 1000 genes.

  2006cites this paper
• Slow-onset inhibition of 2-trans-enoyl-ACP (CoA) reductase from Mycobacterium tuberculosis by an inorganic complex.

  2006cites this paper
• Prioritizing Genomic Drug Targets in Pathogens: Application to Mycobacterium tuberculosis

  2006cites this paper
• Cloning, expression, purification, crystallization and preliminary X-ray diffraction analysis of Rv2827c from Mycobacterium tuberculosis.

  2006cites this paper
• Crystal structure of N-acetyl-gamma-glutamyl-phosphate reductase from Mycobacterium tuberculosis in complex with NADP(+).

  2006cites this paper
• The crystal structure of Rv0793, a hypothetical monooxygenase from M.␣tuberculosis

  2006cites this paper
• Receptor-Binding Sites

  2006cites this paper
• So how do you know you have a macromolecular complex?

  2006cites this paper
• KEMP: A program script for automated biological x-ray absorption spectroscopy data reduction

  2006cites this paper
• Functional linkages can reveal protein complexes for structure determination

  2006cites this paper
• Cloning, expression, purification, crystallization and preliminary X-ray studies of epoxide hydrolases A and B from Mycobacterium tuberculosis.

  2006cites this paper
• The potential impact of structural genomics on tuberculosis drug discovery.

  2006cites this paper
• Current status of some antituberculosis drugs and the development of new antituberculous agents with special reference to their in vitro and in vivo antimicrobial activities.

  2006cites this paper
• The molecular structure of Rv1873, a conserved hypothetical protein from Mycobacterium tuberculosis, at 1.38 A resolution.

  2006cites this paper
• UV laser-excited fluorescence as a tool for the visualization of protein crystals mounted in loops.

  2006cites this paper
• Solution Structure of the Conserved Hypothetical Protein Rv2302 from Mycobacterium tuberculosis

  2006cites this paper
• The molecular structure of Rv2074, a probable pyridoxine 5'-phosphate oxidase from Mycobacterium tuberculosis, at 1.6 angstroms resolution.

  2006cites this paper
• Expression, purification, crystallization and preliminary X-ray analysis of two arginine-biosynthetic enzymes from Mycobacterium tuberculosis.

  2006cites this paper
• The PIN-domain toxin-antitoxin array in mycobacteria.

  2005cites this paper
• Characterization of phylogenetically distant members of the adenylate cyclase family from mycobacteria: Rv1647 from Mycobacterium tuberculosis and its orthologue ML1399 from M. leprae.

  2005cites this paper
• Structure of pyrR (Rv1379) from Mycobacterium tuberculosis: a persistence gene and protein drug target.

  2005cites this paper
• Structures of Mycobacterium tuberculosispyridoxine 5'-phosphate oxidase and its complexes with flavin mononucleotide and pyridoxal 5'-phosphate.

  2005cites this paper